Electroacupuncture for postoperative pain and gastrointestinal motility after laparoscopic appendectomy (AcuLap): study protocol for a randomized controlled trial
Trials volume 16, Article number: 461 (2015)
Acupuncture is a widely serviced complementary medicine. Although acupuncture is suggested for managing postoperative ileus and pain, supporting evidence is weak. The AcuLap trial is designed to provide high-level evidence regarding whether or not electroacupuncture is effective in promoting gastrointestinal motility and controlling pain after laparoscopic surgery.
This study is a prospective randomized controlled trial with a three-arm, parallel-group structure evaluating the efficacy of electroacupuncture for gastrointestinal motility and postoperative pain after laparoscopic appendectomy. Patients with appendicitis undergoing laparoscopic surgery are included and randomized into three groups: 1) electroacupuncture group, 2) sham acupuncture group, and 3) control group. Patients receive 1) acupuncture with electrostimulation or 2) fake electroacupuncture with sham device twice a day or 3) no acupuncture after laparoscopic appendectomy. The primary outcome is time to first passing flatus after operation. Secondary outcomes include postoperative pain, analgesics, nausea/vomiting, bowel motility, time to tolerable diet, complications, hospital stay, readmission rates, time to recovery, quality of life, medical costs, and protocol failure rate. Patients and hospital staff (physicians and nurses) are blinded to which group the patient is assigned, electroacupuncture or sham acupuncture. Data analysis personnel are blinded to group assignment among all three groups. Estimated sample size to detect a minimum difference of time to first flatus with 80 % power, 5 % significance, and 10 % drop rate is 29 × 3 groups = 87 patients. Analysis will be performed according to the intention-to-treat principle.
The AcuLap trial will provide evidence on the merits and/or demerits of electroacupuncture for bowel motility recovery and pain relief after laparoscopic appendectomy.
The trial was registered in Clinical Research Information Service (CRiS), Republic of Korea (KCT0001486) on 14 May 2015.
With advances in surgery, Enhanced Recovery After Surgery (ERAS) programs enable faster recovery after surgery. The theoretical background of an ERAS program is that minimizing pain and stress in patients undergoing surgery prevents organ dysfunction and complications and consequently enhances faster recovery. The clinical significance of ERAS programs has been proven via many clinical studies. Early enteral feeding with fast bowel motility recovery, and resultant fast recovery and shortened hospital stay are advantages of ERAS programs [1–7].
The key elements of an ERAS program include 1) patient information, 2) preservation of gastrointestinal function, 3) minimization of organ dysfunction, 4) active pain control, and 5) promotion of patient autonomy [8, 9]. Many surgery centers are adopting ERAS programs and trying to enhance recovery of surgical patients by means of preserving gastrointestinal function and adequately controlling postoperative pain.
Meanwhile, we searched the literature to find other factors for recovery of surgical patients, and the literature review revealed that electroacupuncture might have positive effects on postoperative bowel motility recovery and pain control [10, 11]. Accordingly, we assumed that electroacupuncture, which is not included in existing ERAS programs, could accelerate recovery after surgery by means of postoperative pain control and faster bowel motility recovery.
This study aims to evaluate the postoperative effect of electroacupuncture on bowel motility recovery and pain relief in patients undergoing laparoscopic appendectomy.
The AcuLap trial is a single-center, prospective randomized controlled trial with a three-arm, parallel-group design (Fig. 1). Data analysis will be performed according to the intention-to-treat principle.
Methods: participants, interventions, and outcomes
Patients diagnosed with appendicitis and undergoing laparoscopic appendectomy at Dongguk University Gyeongju Hospital will be recruited.
History taking and physical examination
Laboratory test including CBC (complete blood count), CRP (C-reactive protein), serum chemistry, and urinalysis
Radiologic test including abdominal X-ray and CT (computed tomography) scan or ultrasonography.
Inclusion criteria include the following:
Patients diagnosed with appendicitis
Patients over 20 years old
Patients undergoing laparoscopic appendectomy
Exclusion criteria include the following:
Patients who need simultaneous combined surgery (including ileocecectomy)
Patients diagnosed with combined other diseases as well as appendicitis, preoperatively or intraoperatively (such as colonic diverticulitis, inflammatory bowel disease, and pelvic inflammatory disease)
Patients who need postoperative fasting according to preoperative evaluation or intraoperative findings (for example, panperitonitis with intraperitoneal abscess)
Patients under treatment for acute disease other than appendicitis
Patients converted to open surgery
Patients with cardiac pacemaker
Patients with allergy to or phobia of acupuncture needle or electrostimulation
Patients with history of syncope or seizure
Pregnant women or lactating women
Patients with history of abdominal surgery
Patients with American Society of Anesthesiologists (ASA) physical status classification IV
Patients who do not consent to clinical trial
Patients incapable of reading, understanding, and signing a written consent form (for example, people who are mentally retarded, blinded, illiterate, or foreigners)
Inmates of a prison or institution/hospital
The study will be conducted in the Department of Surgery, Dongguk University Gyeongju Hospital, Korea.
Laparoscopic appendectomy will be performed by three board certified surgeons with minimum experience of 8 years.
Acupuncture will be performed by two board certified oriental medicine doctors with minimum experience of 10 years.
Patients with appendicitis undergoing laparoscopic surgery are included and randomized into three groups: 1) electroacupuncture group, 2) sham acupuncture group, and 3) no acupuncture group. Patient allocation is performed by block randomization.
After laparoscopic appendectomy, routine postoperative care is equally given to all patients except for interventions (electroacupuncture or sham acupuncture). Clinical outcomes including postoperative pain score and bowel motility recovery are evaluated in each of the three groups during hospitalization. Quality of life and medical cost are evaluated after discharge.
Intervention group I: true electroacupuncture
Patients in the electroacupuncture group receive acupuncture with electrostimulation with stainless steel needles and a PG-306 electroacupuncture device after the operation. At least 2 hours after the operation, electroacupuncture is given for 30 minutes, twice a day, with a minimum interval of 4 hours between the morning session and afternoon session, starting on operation day. A maximum of four acupuncture treatments are performed during hospitalization. This acupuncture schedule is set from the literature review  and in consideration of the usual hospital stay after laparoscopic appendectomy.
Acupuncture is performed by Korean board certified oriental medicine doctors with 10 years of experience in acupuncture. Acupuncture sites (locations) are the following which are known to control pain and promote gastrointestinal motility: LI4 (Hapgok, Hegu), PC6 (Naegwan, Neiguan), KI6 (Johae, Zhaohai), and LR3 (Taechung, Taichong). Those acupoints are selected because they are well-known meridians for treating gastrointestinal disorders including low abdominal pain and are currently employed in our Korean oriental medical clinic.
Patients, physicians, and nurses are blinded to which intervention patients are allocated, electroacupuncture versus sham acupuncture.
Intervention group II: sham electroacupuncture
Patients in the sham acupuncture group receive fake electroacupuncture with a Park Sham Device (PSD). The PSD is a device designed for sham acupuncture which gives little stimulation but a fake sound. The PSD has a PG-306 electric pulse generator, just as in the true acupuncture. However, in the PSD, the internal wire inside PG-306 is cut so as not to deliver the electric pulse to patients, and the patients only hear continuous sound (fake sound) which resembles the electrostimulation.
Schedules for service and acupuncture sites are the same as in the electroacupuncture group.
Patients, physicians, and nurses are blinded to which intervention patients are allocated, electroacupuncture versus sham acupuncture.
Patients in the control group receive routine standard postoperative care without acupuncture.
Routine postoperative care for all participants
Routine NSAID (nonsteroidal anti-inflammatory drug) injection for postoperative pain control every 8 hours/additional injection on patient’s request
Start sips of water after bowel sound is checked by auscultation, unless patient complains of nausea or vomiting
Start soft diet after sips of water when patient is able to walk independently without nausea or vomiting
No patient controlled anesthesia (PCA)
The primary outcome is time to first passing flatus after operation.
Secondary outcomes include postoperative pain, analgesics, nausea/vomiting, bowel motility, time to tolerable diet, complications, hospital stay, readmission rates, time to recovery, quality of life, medical costs, and protocol failure rate.
Postoperative pain will be checked regularly three times a day and will be recorded using the visual analog scale.
Intravenous analgesic injections will be counted daily.
Nausea and vomiting will be counted daily.
Bowel motility will be checked regularly three times a day, by attending surgeons. Bowel sound will be counted in a minute by auscultation.
Postoperative complications will be checked according to Accordion Severity Classification of Postoperative Complications .
Time to recovery is defined as time to ambulate and perform self-care by patient himself or herself.
Discharge is recommended when the patient meets discharge criteria as follows:
Controllable pain with analgesics
Passing flatus or feces
Toleration of soft diet
Mobilization (independent walking) and self-care
Controlled complications less than moderate by Accordion system (Table 1)
Quality of life will be assessed by SF-36 Health Survey questionnaire , on first outpatient clinic visit.
Patient enrollment will be done before operation. After eligibility screen, an informed consent will be obtained at outpatient clinic, emergency department, or ward. After enrollment, random allocation will be performed using blocks. The interventions (electroacupuncture or sham electroacupuncture) will be given twice a day after operation, from operation day to postoperative day 2. All clinical outcome variables will be assessed from operation day until discharge day; except for quality of life, readmission, medical costs, and protocol failure, which will be assessed on the first visit day (postoperative day 7) after discharge (Table 2).
The primary endpoint is time to first passing flatus, which is defined as hours between end of operation and first flatus after operation. To calculate the sample size, a literature review was performed on acupuncture and its effect on bowel motility after laparoscopic surgery. The most similar study to this trial is that of Yu et al. . They measured flatus time after laparoscopic cholecystectomy in an electric acupuncture group (n = 30), analgesia-pumper group (n = 30), and a control group (n = 30). The flatus time was shorter in the electric acupuncture group as compared with the other two groups [(14.77 ± 4.99) hours versus (18.50 ± 4.22) hours, P < 0.01; (14.77 ± 4.99) hours versus (18.17 ± 4.69) hours, P < 0.05].
For the AcuLap trial, the estimated number of participants to detect a minimum difference of time to first flatus with 80 % power, 5 % significance, and 10 % drop rate is 29 × 3 groups = 87 patients.
Methods: assignment of interventions
Allocation sequence will be generated using block randomization with StatsDirect 3 software by a randomizing person at the study center. After obtaining an informed consent from an eligible patient, the recruiter will be given a treatment code assigned to the patient from the centrally generated allocation sequence to which access is restricted for the recruiter.
Two of the treatment codes are electroacupuncture and sham electroacupuncture; and the other code is control. Patients, physicians/nurses, and data analyzers are blinded between electroacupuncture and sham electroacupuncture. Only oriental medicine doctors who perform acupuncture know which treatment code corresponds to which procedure between two interventions.
The control group cannot be blinded.
Methods: data collection, management, and analysis
Data collection methods
All data will be collected using the daily assessment form and will be recorded in case record form, from operation day to discharge day (Table 3). Postoperatively, on the first visit to the outpatient clinic, a quality of life questionnaire (SF-36) will be filled in by the patient.
Analysis of primary outcome:
Median of first flatus time will be analyzed by the Student’s t-test. P values less than 0.05 will be regarded as statistically significant.
Analysis of secondary outcomes:
Categorical data will be analyzed by the chi-square test or Fisher’s exact test. Continuous data will be analyzed by the unpaired t-test or Wilcoxon’s rank sum test. P values less than 0.05 will be regarded as statistically significant.
Missing data less than 5 % of the sample will be dropped. For missing data that amount to more than 5 %, analysis will be carried out with missing data imputation by the last observation carried forward and the maximum likelihood estimation method.
This trial is conducted in accordance with the principles of the Declaration of Helsinki and good clinical practice guidelines.
Research ethics approval
The independent medical ethics committee (Institutional Review Board of Dongguk University Gyeongju Hospital, Korea) has approved this trial (approval number: 110757-201410-HR-04-04). The trial was registered on 14 May 2015 at Clinical Research Information Service (CRiS), Republic of Korea (registration number: KCT0001486).
Attending surgeons will obtain written informed consent from all trial participants before inclusion. All collected data will be kept confidential at all times.
Garcia et al. reviewed 41 randomized controlled trials (RCTs) evaluating the efficacy of acupuncture for symptom management in patients with cancer . Pain, nausea, and postoperative ileus were the most commonly studied symptoms. Among those RCTs, only one study, by Shen et al. , showed a positive conclusion for nausea with low risk of bias. For symptoms other than nausea, the efficacy of acupuncture remained undetermined because of the high risk of bias. Eleven RCTs on pain [17–27], 10 RCTs on nausea [24, 28–36], and 8 RCTs on ileus [17, 18, 23, 37–41] were identified as having high or unclear risk of bias and showed positive or negative conclusions for each symptom.
From the literature review, we concluded that acupuncture needs to be studied with a more sophisticated design to justify its unproven efficacy. The AcuLap trial aims to evaluate the postoperative effect of electroacupuncture on bowel motility recovery and pain relief in patients undergoing laparoscopic appendectomy. We anticipate that the trial will provide high-level evidence on the merits and/or demerits of electroacupuncture after laparoscopic surgery.
The strength of this study lies in proving the true effect of acupuncture on postoperative recovery by comparing patients receiving true acupuncture or sham acupuncture and a control group. If the true acupuncture group shows a better outcome compared to the sham group, the true effect of acupuncture can be justified on postsurgical patients. However, if the true acupuncture group fails to show a superior outcome to the sham group, even though the acupuncture group shows better recovery compared to the control group, a placebo effect of acupuncture should be considered. This is the first published protocol in English to investigate the efficacy of acupuncture on postoperative pain and ileus after laparoscopic appendectomy. We hope to share this protocol with any investigators who are interested in acupuncture and postsurgical recovery.
On the other hand, it is possible that the study may not reveal statistically significant positive or negative conclusions, because laparoscopic appendectomy is minimally invasive surgery, and most patients undergoing laparoscopic appendectomy show fast recovery after surgery. However, we hope to design our next study in other surgical procedures using the experiences from this study.
The trial has been open for recruitment since June 2015.
American Society of Anesthesiologists
complete blood count
Enhanced Recovery After Surgery
acupoint Johae, Zhaohai
acupoint Hapgok, Hegu
acupoint Taechung, Taichong
nonsteroidal anti-inflammatory drug
acupoint Naegwan, Neiguan
patient controlled anesthesia
an electric pulse generator used for electroacupuncture manufactured by Suzuki, Japan
Park Sham Device, a device designed for sham acupuncture
a health survey questionnaire designed for evaluating quality of life
Nicholson A, Lowe MC, Parker J, Lewis SR, Alderson P, Smith AF. Systematic review and meta-analysis of enhanced recovery programmes in surgical patients. Br J Surg. 2014;101:172–88.
Rockall TA, Demartines N. Laparoscopy in the era of enhanced recovery. Best Pract Res Clin Gastroenterol. 2014;28:133–42.
Varut L. Impact of enhanced recovery program on colorectal cancer surgery. Asian Pac J Cancer Prev. 2014;15:3825–8.
Zhuang C-L, Ye X-Z, Zhang X-D, Chen B-C, Yu Z. Enhanced recovery after surgery programs versus traditional care for colorectal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2013;56:667–78.
Lee T-G, Kang S-B, Kim D-W, Hong S, Heo SC, Park KJ. Comparison of early mobilization and diet rehabilitation program with conventional care after laparoscopic colon surgery: a prospective randomized controlled trial. Dis Colon Rectum. 2011;54:21–8.
Donohoe CL, Nguyen M, Cook J, Murray SG, Chen N, Zaki F, et al. Fast-track protocols in colorectal surgery. Surgeon. 2011;9:95–103.
Kehlet H. Fast-track colorectal surgery. Lancet. 2008;371:791–3.
Kehlet H, Dahl JB. Anesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–8.
Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002;183:630–41.
Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang P, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31:952–60.
Ng SSM, Leung WW, Mak TWC, Hon SSF, Li JCM, Wong CYN, et al. Electroacupuncture reduces duration of postoperative ileus after laparoscopic surgery for colorectal cancer. Gastroenterol. 2013;144:307–13.
Deng G, Wong WD, Guillem J, Chan Y, Affuso T, Yeung KS, et al. Randomized controlled trial of acupuncture for reduction of postcolectomy ileus. Ann Surg Oncol. 2015;20:1164–9.
Strasberg SM, Linehan DC, Hawkins WG. The Accordion Severity Grading System of surgical complications. Ann Surg. 2009;250:177–86.
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
Yu GJ, Fu GQ, Li FR, Li LH, Guo F, Xue H, et al. Efficacy on analgesia with electric stimulation of long-term retaining needle after laparoscopic cholecystectomy. Zhongguo Zhen Jiu. 2014;34:169–72.
Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA. 2000;284:2755–61.
Li QS, Cao SH, Xie GM, Gan YH, Ma HJ, Lu JZ, et al. Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer. Chin Med J. 1994;107:289–94.
Poulain P, Leandri EP, Laplanche A, Montange F, Bouzy J, Truffa-Bachi J. Electroacupuncture analgesia in major abdominal and pelvic surgery: a randomised study. Acupunct Med. 1997;15:10–3.
Dang W, Yang J. Clinical study on acupuncture treatment of stomach carcinoma pain. J Tradit Chin Med. 1998;18:31–8.
Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003;21:4120–6.
Wong RH, Lee TW, Sihoe AD, Wan IY, Ng CS, Chan SK, et al. Analgesic effect of electroacupuncture in postthoracotomy pain: a prospective randomized trial. Ann Thorac Surg. 2006;81:2031–6.
Crew KD, Capodice JL, Greenlee H, Apollo A, Jacobson JS, Raptis G, et al. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. J Cancer Surviv. 2007;1:283–91.
He BM, Li WS, Li WY. Effect of previous analgesia of scalp acupuncture on post-operative epidural morphine analgesia in the patient of intestinal cancer. Zhongguo Zhenjiu. 2007;27:369–71.
Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, et al. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage. 2007;33:258–66.
Deng G, Rusch V, Vickers A, Malhotra V, Ginex P, Downey R, et al. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. J Thorac Cardiovasc Surg. 2008;136:1464–9.
Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol. 2010;28:1154–60.
Pfister DG, Cassileth BR, Deng GE, Yeung KS, Lee JS, Garrity D, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010;28:2565–70.
Xia YQ, Zhang D, Yang CX, Xu HL, Li Y, Ma LT. An approach to the effect on tumors of acupuncture in combination with radiotherapy or chemotherapy. J Tradit Chin Med. 1986;6:23–6.
Dundee JW, Ghaly RG, Fitzpatrick KT, Lynch GA, Abram WP. Acupuncture to prevent cisplatin-associated vomiting. Lancet. 1987;1:1083.
Dundee JW, Ghaly RG, Fitzpatrick KT. Randomised comparison of the antiemetic effects of metoclopramide and electro-acupuncture in cancer chemotherapy. Br J Clin Pharmacol. 1988;25:678–9.
Streitberger K, Friedrich-Rust M, Bardenheuer H, Unnebrink K, Windeler J, Goldschmidt H, et al. Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial. Clin Cancer Res. 2003;9:2538–44.
Melchart D, Ihbe-Heffinger A, Leps B, von Schilling C, Linde K. Acupuncture and acupressure for the prevention of chemotherapy-induced nausea: a randomized cross-over pilot study. Support Care Cancer. 2006;14:878–82.
Gottschling S, Reindl TK, Meyer S, Berrang J, Henze G, Graeber S, et al. Acupuncture to alleviate chemotherapy-induced nausea and vomiting in pediatric oncology: a randomized multicenter crossover pilot trial. Klin Padiatr. 2008;220:365–70.
Yang Y, Zhang Y, Jing NC, Lu Y, Xiao HY, Xu GL, et al. Electroacupuncture at Zusanli (ST 36) for treatment of nausea and vomiting caused by the chemotherapy of the malignant tumor: a multicentral randomized controlled trial. Zhongguo Zhenjiu. 2009;29:955–8.
Enblom A, Tomasson A, Hammar M, Steineck G, Borjeson S. Pilot testing of methods for evaluation of acupuncture for emesis during radiotherapy: a randomized single subject experimental design. Acupunct Med. 2011;29:94–102.
Enblom A, Johnsson A, Hammar M, Onelov E, Steineck G, Borjeson S. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea: a randomized controlled study. Ann Oncol. 2012;23:1353–61.
Garcia MK, Skibber JM, Rodriguez-Bigas MA, Chang DZ, Feig BW, Bisanz AK, et al. Acupuncture to prevent prolonged postoperative ileus: a randomized controlled trial. Med Acupunct. 2008;20:83–8.
Yin SH, Du YQ, Liu B. Clinical study on acupuncture combined with medication in restoration of gastrointestinal functions for postoperative patients with gastric cancer. Zhongguo Zhenjiu. 2009;29:459–62.
Meng ZQ, Garcia MK, Chiang JS, Peng HT, Shi YQ, Fu J, et al. Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial. World J Gastroenterol. 2010;16:104–11.
Sun BM, Luo M, Wu SB, Shen XX, Wu MC. Acupuncture versus metoclopramide in treatment of postoperative gastroparesis syndrome in abdominal surgical patients: a randomized controlled trial. J Chin Integr Med. 2010;8:641–4.
Du YQ, Zhang SY. Use of Jiangqi Hewei Tongfu method to improve gastrointestinal function and immune function in patients with intestinal tumors after surgery. World Chin J Digestol. 2011;19:687–92.
First, the author would like to thank Professor Gyeong-Ho Kim (Department of Acupuncture, Dongguk University Gyeongju Oriental Medicine Clinic) for his valuable contribution to the acupuncture practice. Also, I would like to thank Professor Kwan Lee (Department of Preventive Medicine, Dongguk University College of Medicine) for his support with statistics. I want to thank Professor Ki-Hun Jeong and Professor Ho-Geun Jeong (Department of Surgery, Dongguk University College of Medicine) for participating in the trial as attending surgeons. Finally, I want to thank all members of the Department of Surgery of Dongguk University Gyeongju Hospital for their cooperation. The AcuLap trial has been funded by a grant from the Daegu-Gyeongbuk Surgical Society research foundation, Korea, 2014.
The principal investigators declare that they have no competing interests.
About this article
Cite this article
Kim, G. Electroacupuncture for postoperative pain and gastrointestinal motility after laparoscopic appendectomy (AcuLap): study protocol for a randomized controlled trial. Trials 16, 461 (2015). https://doi.org/10.1186/s13063-015-0981-x